THE OPTION VALUE OF AN EARLY‐STAGE BIOTECHNOLOGY INVESTMENT
- 1 December 2002
- journal article
- Published by Wiley in Journal of Applied Corporate Finance
- Vol. 15 (2) , 44-55
- https://doi.org/10.1111/j.1745-6622.2002.tb00694.x
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit:
- VALUE CREATION AT ANHEUSER‐BUSCH: A REAL OPTIONS EXAMPLEJournal of Applied Corporate Finance, 2001